Ness

<p align="center"><strong><em>FDA cleared the IND for OcuRing™-K, enabling a U.S. multi-center Phase II trial in cataract surgery with patient enrollment expected in the second half of 2026</em></strong></p>

Sep 3, 2026

<p align="justify"><strong>Ness Ziona, Israel, Sept. 03, 2026 (GLOBE NEWSWIRE) -- </strong> Steakholder Foods Ltd. (Nasdaq: STKH), a global leader in 3D-printing technology for production of whole cuts of plant-based meat, today announced the launch of <b>Perfecta™ Premium Plant-Based Meat</b> at retail locations across the Northeastern United States, marking the brand's first commercial placement on U.S. store shelves and an important milestone in the Company's growth strategy. The rollout is being supported through distribution with <b>KeHE Distributors</b>, one of the nation's leading natural and specialty food distributors.</p>

Sep 3, 2026

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxPWWs4ZFpRdU9odmVja0wtNUxZWWlZazJjSmc3b0pwR0JlYlpsQVNPQzRpMnVYX1F4dnIwOHRUejhXNXI0R1V3OXpITEQyVkVjUGRmcUVQS3dSZXJXOWF5akJmSk93RG9OTU41MElqTmRSZm5LVHBJLU13bm4wSkhlZ1ZPUHNWWVBKcEVzTDBaNmV1MVkzZHRR?oc=5" target="_blank">Anthropic expanding Israel marketing and sales</a>&nbsp;&nbsp;<font color="#6f6f6f">Globes - Israel Business News</font>

Sep 2, 2026

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxOLU9XOWxQZDVpdGxrcTd0LTdLUGJzRnIwcE53QU92Y0ZMSjZhSm4zSW9IdERhZmVfSmxVbTZHd09IaDNtd19OQzBDTUhHcjMxX09sUFhqYTdYVGpJZFJ3MVJwR2RtRjRzdzVjT1BGdURLTEhyU01fR2drSHZwd0ZRdERzbXVNQWJVdnlN?oc=5" target="_blank">Dana Nessel Is Wrong About What Judaism Asks of Us</a>&nbsp;&nbsp;<font color="#6f6f6f">The Times of Israel</font>

Sep 2, 2026

<a href="https://news.google.com/rss/articles/CBMieEFVX3lxTFBHU0VweV9vSEprbzlobHJPM01qczJUOWNielpBZlRySHNrQ2xDemhWQTNmT2F1akhHemJCX1p1RXA4Nk83dlVBeEhzT2ZSN3ZCb2doOHZnV2JobkR2SGtXaTdJYzFBc25HcXV1RkN5V3Q3ZlN4RDZ2ZA?oc=5" target="_blank">Online entertainment sites in the context of U.S.-Israel business and technology</a>&nbsp;&nbsp;<font color="#6f6f6f">The Jerusalem Post</font>

Sep 1, 2026

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxPZ2t5ak45S1NYU0R3SlNFME1GbGt0T1l6dVY5M0tNLVlFUEdVZkhJdV9QOHdOaHl2YXBPZExJT0xJVHZwenVLbVNDOXV0WkpVQlpXUEtjWFVYVzFkbFlpdEkxcWRYMXk2ajJpUjdUZS0xS0VoR0h3T1BLMGQtb2VmWWpXLVppMEJMSmRoZHVvVXlTdnFHdjJR?oc=5" target="_blank">Dana Nessel, Who Gave You the Right to Volunteer My Survival?</a>&nbsp;&nbsp;<font color="#6f6f6f">The Times of Israel</font>

Sep 1, 2026

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxOZUJBOGdOcm9FTFJIOTdzUWVncjdnZVl6MXdCdDltNzg0a3lmT1ZLTFNYQ2FOSXlENDFibDhWZmFRRkQ1V3o5eFBSNklQYjhTcUJWZ2JIN0RSM3ZtdEhUdVdBa2ZLSEpKSGdKTFVXaXBMeG82VDBRTTNjSHhmaVkyVkczZGpfdkNNMEF1bi1PeXJMR2VzNnJLQk9NX1BIa3k1NnZpaGln?oc=5" target="_blank">The Emerging Business of Cognitive Warfare: An India–Israel Opportunity</a>&nbsp;&nbsp;<font color="#6f6f6f">The Times of Israel</font>

Aug 30, 2026

Teva Pharmaceuticals proposes acquiring BXCL501, expanding its neuroscience portfolio with a novel agitation treatment under FDA review

Aug 28, 2026

<p align="justify" style="padding-left: 0pt;">HAIFA, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri”), a biotechnology company, leveraging its proprietary three-dimensional ("3D") cell expansion platform across two principal business verticals: (i) Human Health &amp; Longevity and (ii) FoodTech &amp; Bio-Farming, today announced that it has entered into a securities purchase agreement with a single healthcare focused institutional investor, for the purchase and sale of 2,228,940 Common Shares (or Common Share equivalents in lieu thereof) at a purchase price of $1.50 per share in a registered direct offering. The gross proceeds from the offering are expected to be approximately $3.3 million, before deducting placement agent commissions and other offering expenses. In addition, in a concurrent private placement, Pluri will issue and sell unregistered warrants to purchase up to 2,228,940 Common Shares (the “Warrants”). The Warrants will have an exercise price of $1.65 per share, will be initially exercisable six months following the date of issuance, and will expire five and a half years from the date of issuance.</p>

Aug 27, 2026

<a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTFB0NUxISHAwR2NNVEZwd0FEc0MwVDJpNVQwVVJPazRtbHNpYjVyRE5CSWNOSVdPWFRvV0VabWVUZm43VV9jS0txUTBMRzZKZmc4SU5GNTVmb05Lcnd1T1hydFFncnZPUlk?oc=5" target="_blank">“AI-nativeness exists on a spectrum; the underlying criteria for a strong business do not.”</a>&nbsp;&nbsp;<font color="#6f6f6f">calcalistech.com</font>

Aug 26, 2026

New initiative connects proven construction, infrastructure, and municipal technology startups with experienced local partners across the USA, Europe, the GCC, Asia, South America and Australia <pre>New initiative connects proven construction, infrastructure, and municipal technology startups with experienced local partners across the USA, Europe, the GCC, Asia, South America and Australia</pre>

Aug 26, 2026

<p align="left">PETACH TIKVA, Israel, Aug. 25, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended June 30, 2026, before market open on Wednesday, September 9, 2026. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Guy Nathanzon, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.</p>

Aug 25, 2026

<p align="center"><i>Order for compact day and thermal imaging solution reflects continued demand across Maris-Tech’s situational awareness portfolio</i></p>

Aug 25, 2026

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxNLVQtZmZQTHROM25DeFo4LVZnR1BuZ21aSGJFc2lBZnlxcnd0WkJhSXdlRkQ3ckI5LS1BOUZDUVBkN0RoZ0ZMZnI2REIyZUFnT2VhM2NaSVdLSlJMY1FBa3h5V1RkYk5kYjhqaVdiN25YQVFtWHFWdFJZVmJoVTRsSi1iR1B2dkNPVUZZSXpmSjZ0cmxYOU9qYUI0eUVpZ25jblF1d19FVVFRZndWcUE?oc=5" target="_blank">From Remittances to Investment: Building an Israel–Somaliland Business Bridge</a>&nbsp;&nbsp;<font color="#6f6f6f">The Times of Israel</font>

Aug 21, 2026

<p align="justify"><i>Company explores additional growth opportunities, including the possible acquisition of AI-Based Technologies, Cybersecurity or Data Centers, while continuing its existing business activities</i></p>

Aug 21, 2026

<p align="justify">NESS ZIONA, Israel, Aug. 20, 2026 (GLOBE NEWSWIRE) -- <strong>Sol-Gel Technologies, Ltd.</strong> (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today announced financial results for the second quarter ended June 30, 2026, and provided a corporate update.</p>

Aug 20, 2026

<p align="center"><em>Appointed Pharma Industry Veteran </em><em>Brendan O’Grady as Chief Executive Officer</em></p>

Aug 17, 2026

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNWWpfMk1tdWtYMDIxYVdqaGhMMTgxaEkwVXZnNnBwYjdkTzhLQWhoQ1MtUzJEYUE1QnNQbUh5dUYwUlU1MkNmUjRILUZyODVoenZieVB3NzlkbVdtcnlObmE5VzFKNjYwaDUwSXg3bFFWVmJjdUM5LWlhUXo3Q3lfV1J3SndfVnVEQnF1eWwwU2tLU1ZuYTJaRzRzTFlURkFMd3pmOW54UUhqUWlM?oc=5" target="_blank">Anthropic acquisition to make Decart founders billionaires</a>&nbsp;&nbsp;<font color="#6f6f6f">Globes - Israel Business News</font>

Aug 16, 2026

<p align="justify">NESS ZIONA, Israel, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in 3D perception systems, today reported financial results for the second quarter and first half of 2026.</p>

Aug 14, 2026

<p align="justify"><strong>Ramat Gan, Israel, Aug. 13, 2026 (GLOBE NEWSWIRE) -- </strong>Odysight.ai Inc. (NASDAQ/TASE: ODYS), a leader in AI-powered visual sensing and predictive maintenance (PdM) solutions for the aerospace, defense, and industrial markets, today announces its financial results for the first half of 2026, and provides a business update.</p>

Aug 13, 2026

<p align="center"><i>Expanded 2026 Israel Electric Corporation IC Drone Grid-Maintenance Season Commenced; Purchase Order on Track to Generate the Expected More Than $1 Million in Revenue During 2026</i></p>

Aug 13, 2026

<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxNX0ptdklEMi1xanRueDFPOXBUUEtZSmJQX1diLTd4TzRCZ1hPTnZQQV9sdmxuTUh0YjNRMDhZUWo3ZzdLbEV5RmpMWnI4R3gtZl9heTRDVW5EVnpINGd4cnZ5NG1WSnlLSnJvZHFPT0hDN2YtTm1ud1NjeVRtOE50VEV3?oc=5" target="_blank">What Anthropic seeks in Israel's Decart</a>&nbsp;&nbsp;<font color="#6f6f6f">Globes - Israel Business News</font>

Aug 13, 2026

<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxObS0zN2RieGRXaHNnNFFEZWZub1dEaU9RQ2xuRkRvZklTQlFad2pJWmZqWUY3cmY0NHhVN29FSmIyODFHY2RhenRaenVzVGlyZWctV1N3amNrclFNekdheUlIN1loUjQzbXFFSlVoYURGRDloQ3R2dUtsYkZqSTE4NjNVVHV2Vjg1T3h1LU5Jd2hEaldPaXBNeFIydEdVY29rQTQwQ0pBbl8zUkM4cmtOZVJwbzQ2VjNzeXFQYTNQM2p5eE5Y?oc=5" target="_blank">Anthropic in Talks to Acquire Israeli AI Startup Decart for $6 Billion</a>&nbsp;&nbsp;<font color="#6f6f6f">Asia Business Outlook</font>

Aug 13, 2026

<p align="justify">NESS ZIONA, Israel, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd. (“Mapi” or the “Company”), a late-stage clinical biopharmaceutical company specializing in long-acting injectable therapies, today announced initial clinical results from its on-going Phase I/IIa trial that support continued development of once-monthly Cariprazine Depot.</p>

Aug 12, 2026

<p align="center"><em>Kara Puccinelli to assume role of Chief Commercial Officer; Kenneth Suh named Chief Business Officer</em></p>

Aug 12, 2026